Aceclofenac's therapeutic use is documented. The primary clinical areas for which this medication is relevant involve the management of pain and inflammation.

Managing Chronic Pain and Inflammation

Airtal may be part of symptomatic management applied in conditions characterized by periods of heightened symptoms, including Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. It helps address symptom clusters that may become intense or disruptive and are related to inflammatory or irritative states. Applied across domains where additional symptomatic support is needed, it contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability when symptoms interfere with routine activities. It generally provides support that may assist with managing the overall symptom load for patients managing long-term discomfort.

“It is used for managing symptoms that interfere with daily functioning.”

Relief for Acute and Localized Musculoskeletal Pain

The medication is considered relevant for managing acute, localized musculoskeletal pain and inflammation, such as in acute episodes of lumbago (low back pain) or pain arising from soft tissue rheumatic disorders. Used during phases when symptoms become more noticeable, it is applied in clinical settings where short-term symptomatic assistance is needed. This provides supportive relief when symptoms temporarily escalate, and may help patients cope more steadily with physical discomfort during symptomatic periods.

---

Quick Fact: Supports Management of Joint Discomfort Airtal is commonly used to help address symptoms related to physical discomfort and functional strain associated with chronic joint conditions.

Who Can and Cannot Use Airtal? — Official Regulatory Information

Airtal (aceclofenac) is generally approved for use in adults who do not possess any contraindications. Eligibility for this medicine is strictly defined by government regulatory documents, which list conditions and patient populations where use is restricted or prohibited.

Contraindications (Must Not Use)

Official labels state that Airtal is contraindicated in patients with:

• Hypersensitivity to aceclofenac or any other Non-Steroidal Anti-Inflammatory Drug (NSAID), such as aspirin, which may trigger asthma or rhinitis.
• Active or a history of recurrent peptic ulcers, gastrointestinal bleeding, or perforation.
• Severe failure of the renal or hepatic (liver) systems.
• Established severe cardiovascular disease, including severe heart failure (NYHA Class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.
• Third trimester of pregnancy.

Age and Physiological Restrictions

Population	Eligibility Status (as per regulatory label)
Children/Adolescents (< 18 yrs)	Not recommended; safety and efficacy have not been established.
Elderly Patients	Use permitted with special caution; the lowest effective dose for the shortest duration is required due to increased risk of severe adverse effects.
Pregnancy/Lactation	Contraindicated in the third trimester. Not recommended during lactation or for women attempting to conceive.
Mild-to-Moderate Impairment	Patients with mild to moderate hepatic or renal impairment require caution, surveillance, and possible dose reduction.

Interactions with Other Medicines and Products

This section outlines the officially documented interaction patterns for Airtal (aceclofenac) as found in government regulatory prescribing information.

Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including aspirin, is strictly advised against due to a heightened risk of adverse effects. Additionally, NSAIDs must not be used for 8 to 12 days following administration of mifepristone as aceclofenac may reduce its intended effect.

Pharmacokinetic interactions involve drugs whose plasma concentrations may be increased. Aceclofenac can decrease the elimination of both Lithium and Methotrexate, resulting in increased systemic exposure to these medicines. Caution is also noted for co-administration with CYP2C9 substrates (e.g., phenytoin, tolbutamide), as aceclofenac may affect their clearance.

Pharmacodynamic Interactions

Interacting Substance	Official Interaction Outcome
Anticoagulants (e.g., Warfarin)	Increased risk of hemorrhage.
Corticosteroids, SSRIs, Anti-platelet Agents	Increased risk of gastrointestinal bleeding.
Diuretics, ACE Inhibitors, ARBs	Reduced antihypertensive effect; increased risk of renal function deterioration.

In relation to substances, taking the medicine with food alters the speed of its absorption, but not the overall exposure. The regulatory label notes that the use of NSAIDs alongside regular alcohol consumption may increase the risk of gastric bleeding.

Enzyme Inhibition and Prostaglandin Suppression

Airtal's core mechanism is the inhibition of Cyclooxygenase (COX) enzymes, particularly COX-2, which are responsible for converting fatty acids into prostaglandins—key local mediators. This action modifies the early molecular steps of the Arachidonic Acid Pathway, leading to a systemic reduction in inflammatory signaling activity.

Modulation of Downstream Signaling

The initial enzyme inhibition triggers a cascade effect that reduces the synthesis of prostaglandins and modulates the expression of certain pro-inflammatory cytokines ( TNF-alpha). This modulation affects the physiological response by altering the chemical sensitization of peripheral nerve endings (nociceptors) and diminishing localized vascular permeability.

Interaction with Connective Tissue Structure

Airtal features a supplementary mechanism where it directly interacts with the metabolism of cartilage. This effect involves both influencing the synthesis of structural components and inhibiting enzymes that degrade joint tissue. This affects the structural environment within connective tissues by shifting the balance away from degradative processes.

The medication Airtal, which contains the active substance aceclofenac, is administered exclusively via the oral route as a 100 mg film-coated tablet. The framework for its use focuses strictly on dose quantity, frequency, and population-specific rules.

Field	Official Administration Guideline
Dosing Schedule	The standard adult dose is 200 mg per day, which is achieved by taking one 100 mg tablet twice per day. The maximum daily dose is 200 mg.
Frequency and Timing	The standard dose is administered twice daily (BID). The tablet must be swallowed whole with liquid and may be taken either with or after food; food intake does not alter the overall amount of drug absorbed.
Course Duration Principle	Treatment must utilize the lowest effective dose for the shortest duration necessary to manage symptoms. Continued use requires periodic re-evaluation of the necessity for the medication.
Population-Specific Rules	For patients with hepatic impairment, the initial daily dose must be reduced to 100 mg once per day. Use in the pediatric population is not recommended due to a lack of clinical data.

The administration protocol is standardized to ensure use is consistent with established parameters, particularly the mandated reduction in dose for patients with impaired hepatic function.

Research Evidence / Overview of Studies

General Profile and Pharmacokinetics

Research examined the profile of Airtal (aceclofenac), a nonsteroidal anti-inflammatory drug (NSAID), in relation to painful conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

The research evaluated the relationship between study participation and changes in symptoms and pain scores. The drug is rapidly absorbed following oral administration, with peak plasma concentrations typically reached within one to three hours.

Studies primarily involved adult subjects; however, bioequivalence studies have been conducted on various formulations in healthy volunteers.

---

Efficacy and Outcomes in Randomized Trials

Studies investigated Airtal in relation to changes in primary symptoms, such as joint swelling and pain intensity. For chronic conditions, randomized controlled trials (RCTs) typically examine subjects over periods such as 12 weeks. The results of these studies were evaluated to determine potential outcomes, often comparing the drug to other common NSAIDs like diclofenac or naproxen.

• Acute Pain: Research has explored the use of Airtal in conditions like acute low back pain and ankle ligament injuries. Studies on acute low back pain have investigated Airtal in fixed-dose combinations (FDCs) with muscle relaxants to see if the combination may influence study outcomes compared to Airtal alone.
• Safety Profile: Controlled studies have assessed the rate of adverse reactions (ARs) associated with Airtal compared to control drugs. The research focus has often included assessing the tolerability of Airtal, particularly concerning gastrointestinal effects.

---

Combination Therapy

Research has explored combining Airtal with other agents, such as proton pump inhibitors (PPIs) or muscle relaxants, to determine if the combination may influence study outcomes or affect drug interactions. For instance, studies have evaluated the pharmacokinetics of Airtal when co-administered with esomeprazole or ilaprazole.

Key Studies & References

1. NICE Guideline: Osteoarthritis: care and management

Common questions about Airtal (FAQ)

---

Q: How quickly does Airtal start working after I take it?

A: Studies on the drug’s profile indicate that the active ingredient, aceclofenac, is rapidly absorbed following oral intake. Official information states that the highest concentration of the medicine in the blood is typically reached within 1.25 to 3 hours after a dose is taken.

Q: How long does the effect of one dose of Airtal typically last?

A: The time it takes for half of the medicine to be eliminated from the bloodstream, known as the mean plasma elimination half-life, is reported to be about 4 to 4.3 hours. The standard administration schedule established in regulatory documents is twice daily.

Q: Does Airtal cause drowsiness or affect driving?

A: Official product information states that aceclofenac may cause common side effects like dizziness and, less often, somnolence (drowsiness) or blurred vision. These effects could potentially impair the ability to drive or safely use machinery. These possible reactions are noted in the official product information.

Q: Can I take Airtal if I have stomach problems or ulcers?

A: Airtal is contraindicated in patients with an active or a history of recurrent peptic ulcers, gastrointestinal bleeding, or perforation. Regulatory documents also state that patients with pre-existing conditions like certain inflammatory bowel diseases require special caution.

Q: Does Airtal interact with blood pressure medications?

A: Yes, official documents note that aceclofenac can interact with certain types of blood pressure medication. It may reduce the intended antihypertensive effect of medicines like diuretics, ACE inhibitors, and ARBs. This information is detailed in the official product labeling.

Q: Can Airtal be taken at the same time as paracetamol (acetaminophen)?

A: Regulatory documents note that co-administration of two or more Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as aspirin, is generally advised against due to an increased risk of adverse effects. Paracetamol is not an NSAID, and the labeling does not specifically address this combination.

Q: Is it safe to drink a moderate amount of alcohol while on Airtal?

A: Official regulatory documents indicate that using NSAIDs, including aceclofenac, alongside regular alcohol consumption may increase the risk of gastrointestinal bleeding. The medicine label does not define what constitutes a 'moderate amount' of alcohol.

Q: Why do official sources limit the maximum daily dose of Airtal?

A: Official sources state that undesirable effects, such as the risk of serious cardiovascular events, are associated with both the dose and the duration of treatment. The limit of 200 mg per day is mandated because risks may be minimized by using the lowest effective dose for the shortest period necessary.

Q: Can Airtal be taken on an empty stomach?

A: The official guidelines state the tablet may be swallowed whole with liquid and may be taken either with or after food. Food intake delays the speed at which the medicine is absorbed, but it does not significantly change the total amount of drug that the body absorbs.

Q: Is Airtal safe to take for a long period of time?

A: The recommended treatment principle is to use the lowest effective dose for the shortest duration necessary to control symptoms. Regulatory documents state that prolonged use requires periodic re-evaluation by a healthcare provider, as risks like serious cardiovascular events may increase with extended treatment.

Q: Are there any foods or drinks I should avoid while using Airtal?

A: Regulatory documents specifically advise caution regarding regular alcohol consumption due to the increased risk of gastric bleeding. No other specific food restrictions or prohibitions are listed in the official product documents.

Q: What happens if I miss a dose of Airtal?

A: The general recommendation found in patient information for this type of medication is to skip a missed dose if it is nearly time for the next scheduled dose, and to not take a double dose. This instruction is based on general guidelines for managing missed doses of twice-daily medication.

Q: Is it normal to feel dizzy when first starting Airtal?

A: Dizziness is officially listed as a Common adverse reaction, meaning it may affect up to 1 in 10 people who take the medicine. This frequency is described generally across the course of treatment, not specifically when first starting therapy.

Q: Can older adults (seniors) use Airtal?

A: Yes, use in elderly patients is generally permitted but official documents require special caution. This is because older adults face an increased risk of severe adverse effects, particularly gastrointestinal complications. The use of the lowest effective dose for the shortest duration is noted in regulatory documents for this population.

Q: Can Airtal affect kidney function?

A: Airtal is contraindicated in cases of severe renal (kidney) failure. Official sources note that uncommon side effects include increases in blood urea and creatinine levels. Like all NSAIDs, it carries a potential risk of affecting kidney function, especially in individuals who are already considered high-risk.

Q: Is there any research on Airtal use in children?

A: Official documents state that the use of Airtal is not recommended in children and adolescents under 18 years of age. This recommendation is based on the fact that safety and efficacy have not been established in this population due to a lack of clinical data.

Q: Are there different strengths of Airtal tablets available?

A: The standard oral film-coated tablet described in primary regulatory documents is 100 mg. However, regulatory sources in various markets have documented the existence of different strengths and formulations, such as extended-release forms, containing 200 mg of the active ingredient.

Q: Can I crush or split Airtal tablets if they are hard to swallow?

A: The patient information leaflet states the tablets must be swallowed whole with a glass of water, and crushing or chewing is not permitted. This instruction is to prevent potential alteration of how the medicine is absorbed or how it is tolerated in the stomach.

Q: Is Airtal available without a prescription in some countries?

A: Airtal is officially classified as a Prescription Only Medicine (Rx) in many regions, including the European Union and the UK. The global regulatory status of aceclofenac varies from country to country, but the US market does not currently have this product approved.

Q: Does using Airtal affect the results of any lab tests?

A: Official side effect lists document occasional occurrences of abnormal laboratory values. These have included elevated liver enzyme levels and increases in serum creatinine and blood urea, which are indicators monitored in routine lab tests.

Q: Is Airtal used for headaches or migraines?

A: The core regulatory indications for Airtal are the relief of pain and inflammation in chronic joint conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Headaches or migraines are not listed as primary therapeutic indications for the single-ingredient product.

Q: Can I use Airtal if I have asthma?

A: Official product information states that the use of Airtal is contraindicated (forbidden) in patients for whom aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) trigger attacks of asthma, rhinitis, or urticaria.

Q: Is there any public interest in new research on Airtal?

A: Yes, public clinical trial registries indicate ongoing research into the medicine. For instance, studies are conducted to compare a new formulation of aceclofenac to existing products to ensure bioequivalence, which relates to how the drug acts in the body.

Q: How is the safety profile of Airtal described in official documents?

A: The safety profile is described as typical for an NSAID, with adverse reactions generally being minor and reversible, most frequently affecting the gastrointestinal system. However, all NSAIDs carry serious warnings regarding the potential for gastrointestinal bleeding and cardiovascular risks.

Q: What is Airtal used for besides common pain?

A: The official therapeutic indications are for the chronic treatment of specific painful and inflammatory conditions primarily affecting the joints. These include osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Q: Is it safe to stop taking Airtal suddenly?

A: Patient information leaflets often advise against discontinuing the use of aceclofenac without first consulting a healthcare provider, as stopping suddenly could potentially lead to the return or worsening of symptoms.

Official Storage and Disposal Requirements

Official regulatory guidelines strictly define the conditions for storing and disposing of Airtal (aceclofenac tablets).

Requirement Type	Official Labeled Instruction
Temperature Limit	Store the product below 25 C (or 30 C, depending on region).
Packaging Mandate	Keep the blister in the original outer carton to protect the tablets from light.
Child Safety	Must be stored out of the sight and reach of children.
Waste Disposal	Do not dispose of unused or expired medicine via wastewater or household waste.
Disposal Protocol	Discard product in accordance with local requirements; consult a pharmacist for guidance.

Storing the medicine according to these rules ensures the integrity of the product throughout its stated shelf life. The environmental disposal requirements are mandatory to prevent the release of aceclofenac into the environment.